Globus MedicalBMO initiated coverage with Outperform rating and $94 price target, citing sector-leading margin growth and Nevro acquisition.
BMO Capital Markets has named Intuitive Surgical, Globus Medical, and Teleflex as its highest-conviction picks in the medical technology sector, initiating coverage with Outperform ratings and calling the beaten-down group a buying opportunity. Analyst Vik Chopra noted that MedTech stocks trade roughly 31% below their 10-year relative average, approaching the widest discount to the S&P 500 in a decade, while demand for hospital procedures remains strong. He attributed the weakness to fund flows and policy noise rather than fundamentals, describing the sector as under-owned and under-appreciated with the marginal buyer absent. Intuitive Surgical, his top pick, trades at about a 31% discount to its three-year historical multiple despite having the strongest fundamental profile among peers. Globus Medical was highlighted for sector-leading margin growth partly driven by its Nevro acquisition, and Teleflex was cited for a 2027 earnings inflection not yet reflected in consensus. Price targets were set at $518 for Intuitive Surgical, $94 for Globus Medical, and $159 for Teleflex.
Globus MedicalBMO initiated coverage with Outperform rating and $94 price target, citing sector-leading margin growth and Nevro acquisition.
Intuitive Surgical IncBMO named Intuitive Surgical as top pick with Outperform rating and $518 price target, noting it trades at a 31% discount to historical multiple despite strong fundamentals.
Alphatec Holdings Inc
Stryker Corporation
Zimmer Biomet Holdings Inc
Align Technology Inc
Henry Schein Inc
Envista Holdings Corp
Solventum Corp.
Dentsply Sirona Inc
Teleflex IncorporatedBMO initiated coverage with Outperform rating and $159 price target, citing a 2027 earnings inflection not yet reflected in consensus.
CONMED Corporation
GE HealthCare Technologies Inc.
Integra LifeSciences Holdings